ETA Navigator

Clinical Trials



Clinical Trials

Thyroid Cancer

A Phase III Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer
This study is currently recruiting participants.
Verified January 2012 by Eisai Inc.

EISAI protocol


Summaries of EUGOGO Studies

Tabella Studio B
Tabella Studio C


HiLo

A multicentre randomised trial of high versus low dose radioiodine, with or without rhTSH, for remnant ablation following surgery for thyroid cancer Chief Investigator: Dr Ujjal Mallick and Dr Clive Harmer

HiLo Summary





Copyright © 2011 European Thyroid Association. All rights reserved.

ETA STANDING OFFICE | EndoScience Endokrinologie Service GmbH | Hopfengartenweg 19 | 90518 Altdorf, Germany
Tel: +49 (0) 6136-762197 | Fax: +49 (0) 6136 761953 | email: euro-thyroid-assoc[at]endoscience.de
Registered Charity No. VR200481

eurothyroid.com: The European Thyroid Association's aims are to promote knowledge in the thyroid field (fundamental and clinical)
and improve knowledge of the thyroid gland and its diseases.

About the ETA | Membership | Guidelines | News | Events | Contact Us

Other ETA websites: www.hotthyroidology.com | eta-crn.eurothyroid.com | www.eugogo.eu

Layout, Design and Hosting by deltacity.NET